Patent · US Active

Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis

US10314843B2 · kind B2 · utility

1Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2017
Grant dateJun 11, 2019
Priority date
Expiry dateApr 14, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for the treatment of neoplasms, in particular, by targeting of quiescent cancer cells with therapeutic agents in combination with other treatments effective against certain neoplastic conditions, in particular, anti-cancer treatment with therapeutic agents that are inhibitors of mitosis (a mitotic inhibitor).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.